PrecisoCare® delivers a complete whole genome sequencing program for newborns — a comprehensive blueprint of your child's DNA that supports early intervention, screening, prevention, and family planning throughout life.
Standard newborn screening tests for a limited number of conditions. Whole genome sequencing goes further — identifying thousands of actionable genetic variants from a single sample, giving care teams the information they need to intervene before symptoms appear.
Genomic findings at birth create a longitudinal health record that informs care decisions across the entire patient lifespan.
Provider-ready reports structured for immediate clinical decision-making — not raw data requiring interpretation from scratch.
Genomic findings inform family planning discussions, carrier status, and hereditary risk for future siblings and extended family.
PrecisoCare® newborn samples are collected using a simple, minimally invasive heel stick — no specialized equipment required. Collection can happen in three settings.
Collected at birth during routine newborn care. Integrates into existing nursery workflows with no disruption to standard protocols.
For critically ill newborns requiring urgent genomic evaluation. Our NICU hotline provides direct clinical support for time-sensitive cases.
Collected at a well-baby visit shortly after discharge. The kit ships directly to the provider's office with everything needed for collection and return.
Every state mandates a newborn blood spot screening panel at birth. These panels test for a defined set of metabolic and genetic conditions — typically 30 to 60 disorders depending on the state.
Whole genome sequencing complements state screening by examining the entire genome — over 20,000 genes — in a single test. Conditions missed by the state panel due to panel limitations, borderline results, or rare variants are identified through WGS, giving families and providers a complete picture from the start.
WGS evaluates thousands of conditions beyond what state-mandated panels screen for.
A single heel stick at birth creates a genomic blueprint that informs care decisions for decades.
Even healthy newborns benefit — establishing a genomic baseline for preventive care, pharmacogenomics, and family planning.
PrecisoCare® newborn WGS is indicated across a range of clinical scenarios — from routine healthy newborn screening to urgent NICU evaluation.
When state screening returns abnormal or borderline results, WGS provides definitive genomic clarification to guide clinical next steps.
Neonates presenting with unexplained deterioration, multi-organ involvement, or failure to thrive where a genetic etiology is suspected.
Clinical presentation consistent with inborn errors of metabolism, mitochondrial dysfunction, or complex metabolic disorders requiring genomic evaluation.
Proactive genomic profiling for healthy newborns — establishing a lifelong blueprint for prevention, pharmacogenomics, and family planning.
Direct access for NICU teams managing time-sensitive genomic cases. Available 24/7 for urgent clinical support and expedited processing requests.
Order directly or request access for your practice. Kits ship within 2 business days. CLIA/CAP certified lab processing included.